- Home
- SURG vs ANVS Comparison
SURG vs ANVS Comparison
Compare SURG & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SURG
- ANVS
- Stock Information
- Founded
- SURG 2006
- ANVS 2008
- Country
- SURG United States
- ANVS United States
- Employees
- SURG N/A
- ANVS N/A
- Industry
- SURG Advertising
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- SURG Consumer Discretionary
- ANVS Health Care
- Exchange
- SURG Nasdaq
- ANVS Nasdaq
- Market Cap
- SURG 27.0M
- ANVS 23.8M
- IPO Year
- SURG N/A
- ANVS 2020
- Fundamental
- Price
- SURG $2.49
- ANVS $1.22
- Analyst Decision
- SURG Strong Buy
- ANVS Strong Buy
- Analyst Count
- SURG 1
- ANVS 5
- Target Price
- SURG $8.50
- ANVS $37.00
- AVG Volume (30 Days)
- SURG 4.8M
- ANVS 233.6K
- Earning Date
- SURG 05-12-2025
- ANVS 05-12-2025
- Dividend Yield
- SURG N/A
- ANVS N/A
- EPS Growth
- SURG N/A
- ANVS N/A
- EPS
- SURG N/A
- ANVS N/A
- Revenue
- SURG $60,881,173.00
- ANVS N/A
- Revenue This Year
- SURG $59.57
- ANVS N/A
- Revenue Next Year
- SURG $75.47
- ANVS N/A
- P/E Ratio
- SURG N/A
- ANVS N/A
- Revenue Growth
- SURG N/A
- ANVS N/A
- 52 Week Low
- SURG $1.05
- ANVS $1.11
- 52 Week High
- SURG $4.38
- ANVS $20.00
- Technical
- Relative Strength Index (RSI)
- SURG 66.39
- ANVS 31.53
- Support Level
- SURG $2.18
- ANVS $1.11
- Resistance Level
- SURG $2.52
- ANVS $1.29
- Average True Range (ATR)
- SURG 0.30
- ANVS 0.15
- MACD
- SURG 0.00
- ANVS 0.02
- Stochastic Oscillator
- SURG 83.12
- ANVS 18.64
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; Lead Generation is a generation and case management solutions company serving law firms in the mass tort industry; and Others. It generates the revenue from Mobile Virtual Network Operator segment.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.